Centessa Pharmaceuticals revenue was $15.00M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $0.0, down 100% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNTA annual revenue was $0.0, with -100% growth year-over-year.
CNTA past revenue growth
How has CNTA's revenue growth performed historically?
On Invalid Date, Centessa Pharmaceuticals (NASDAQ: CNTA) reported Q2 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Centessa Pharmaceuticals's revenue was $0.00.
What was Centessa Pharmaceuticals's revenue in 2024?
Centessa Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
How much does Centessa Pharmaceuticals make in a day?
Based on Centessa Pharmaceuticals annual revenue for the past five years, CNTA makes an average of $3,755.07 per day.
What was Centessa Pharmaceuticals's annual revenue growth in the past year?
As of Q3 2025, Centessa Pharmaceuticals's revenue has grown 118.88% year over year. This is 27.95 percentage points lower than the US Biotechnology industry revenue growth rate of 146.83%. Centessa Pharmaceuticals's revenue in the past year totaled $15.00 million.
How much does Centessa Pharmaceuticals make in a year?
Centessa Pharmaceuticals's revenue by year for the past five years is:
Centessa Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
Centessa Pharmaceuticals's annual revenue for Dec 31, 2023 was $6.85 million, a Infinity% increase from 2022.
Centessa Pharmaceuticals's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Centessa Pharmaceuticals's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
Centessa Pharmaceuticals's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.